Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. - LaMarche MJ; Acker M; Argintaru A; Bauer D; Boisclair J; Chan H; Chen CH; Chen YN; Chen Z; Deng Z; Dore M; Dunstan D; et al. (Journal of medicinal chemistry, 2020)